| Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828) |
|---|
| 06/17/2009 | EP2070940A1 Compounds with anti-inflammatory activity |
| 06/17/2009 | EP2069383A2 Synthetic bile acid composition, method, and preparation |
| 06/17/2009 | EP2069382A1 Process for the selective isolation, purification and separation of monohydroxylated 3,17-diketo-steroid compounds |
| 06/17/2009 | CN101456889A N-(methylmercapto thipcarbonyl)-3-steroid hydrazones compounds, preparation and application thereof |
| 06/17/2009 | CN101456888A Method for preparing methenolone |
| 06/16/2009 | CA2434187C Androgenic 7-substituted 11-halogenated steroids |
| 06/11/2009 | WO2001070093A3 Agents and methods for the prevention of initial onset of cancers, the treatment of cancers, and the recurrence of existing cancers |
| 06/09/2009 | CA2388939C Therapeutic treatments for blood cell deficiencies |
| 06/04/2009 | WO2008157635A3 Synthetic bile acid composition, method, and preparation |
| 06/04/2009 | US20090143349 Steroid tetrol solid state forms |
| 06/03/2009 | CN101445542A Process for preparing desogestrel |
| 06/03/2009 | CN101445541A N-(methylthio-sulfur carbonyl)-17-steroidal hydrazone compound, preparation and application thereof |
| 06/03/2009 | CN101444519A Therapeutic methods and delivery systems utilizing sex steroid precursors |
| 05/27/2009 | CN101440112A Steroid compound and use thereof |
| 05/26/2009 | US7538100 17α-alkyl-17β-oxy-estratrienes and intermediate products for their production, use of the 17α-alkyl-17β-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations |
| 05/26/2009 | US7538099 Antiprogestin method and kit for reducing side effects associated with low dosage HRT, oral contraception and regulating menses |
| 05/20/2009 | CN101434631A Estra nitrate ester medicament for inhibiting angiogenesis |
| 05/19/2009 | US7534780 Estradiol prodrugs |
| 05/19/2009 | US7534779 a steroidal quinol that is converted to a biologically active estrogen compound via enzyme catalyzed reduction; 2-(1-adamantyl)-estra-1,3,5(10)-triene-3,17 beta -diol; estrogen receptors activator; low lipid solubility; cataract, glaucoma, conjunctivitis, diabetic retinopathy |
| 05/14/2009 | WO2009059765A2 Process for the preparation of drospirenone |
| 05/13/2009 | CN101429224A Synthesis of 1,4-diene-6-methylene steroids and midbody thereof |
| 05/12/2009 | CA2315829C Angiostatic agents and compositions for controlling ocular hypertension |
| 05/07/2009 | US20090118356 Neo-tanshinlactone and analogs as potent and selective anti-breast cancer agents |
| 05/07/2009 | US20090118164 Methods and compounds for the targeted delivery of agents to bone for interaction therewith |
| 05/05/2009 | US7528123 Estrogenic estra-1,3,5(10)-trienes with differential effects on the alpha and beta estrogen receptors, having a linear hydrocarbon chain of from 5-9 carbon atoms in position 11 |
| 04/30/2009 | WO2009054725A2 Means and methods for counteracting muscle disorders |
| 04/30/2009 | WO2009053008A1 11β-fluoro-3-acetoxyestra-3,5-diene-17-on and method for the production thereof |
| 04/30/2009 | WO2008145318A3 USE OF α, β-UNSATURATED CARBONYL COMPOUNDS AS QUENCHING REAGENTS FOR BIRCH REDUCTION |
| 04/30/2009 | CA2704049A1 Means and methods for counteracting muscle disorders |
| 04/30/2009 | CA2703292A1 11.beta.-fluoro-3-acetoxyestra-3,5-dien-17-one and method for the production thereof |
| 04/29/2009 | EP2053055A1 11.beta.-fluoro-3-acetoxyestra-3,5-diene-17-one and method for its manufacture |
| 04/29/2009 | EP1416937B1 Prophylactic and therapeutic use of hydroxysteroids |
| 04/29/2009 | CN100482675C Method of synthesizing pig ectohormone |
| 04/28/2009 | US7524970 Compounds |
| 04/28/2009 | US7524835 Tetrol steroids and esters |
| 04/28/2009 | CA2416311C 16alpha-methyl or ethyl substituted estrogens |
| 04/28/2009 | CA2344686C High purity composition comprising (7.alpha.,17.alpha.)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one |
| 04/23/2009 | US20090105205 Methods of treating disease states using antiangiogenic agents |
| 04/23/2009 | US20090105202 Androsterone Derivatives and Method of Use thereof |
| 04/23/2009 | US20090105198 estrone derivatives, used for the treatments of vasomotor symptoms, atrophic vaginitis, osteoporosis, breast and prostate cancers |
| 04/21/2009 | US7521439 Glucocorticoid receptor ligands for the treatment of metabolic disorders |
| 04/16/2009 | WO2008134668A3 Heat-labile prodrugs |
| 04/15/2009 | CN100478350C Preparation and application of 5alpha-androstene-7-methyl-3-hydroxy-17-ketone |
| 04/14/2009 | CA2427817C Estrone-derivatives having cytoprotective activity |
| 04/07/2009 | US7514420 Steroids having 1,8-unsaturation and formulations comprising same |
| 04/01/2009 | CN101396555A Methods and compositions for interferon therapy |
| 04/01/2009 | CN100473660C Process for preparing eplerenone |
| 03/26/2009 | US20090082323 Deuterium-enriched fulvestrant |
| 03/25/2009 | EP1846434B1 NANDROLONE 17ß-CARBONATES |
| 03/19/2009 | WO2009034398A1 Process for the synthesis of 6-hydroxymethyl-l,4- androstadien-3.17-dione |
| 03/19/2009 | WO2009033499A1 Total synthesis of enantiopure desogestrel |
| 03/19/2009 | US20090075964 Fragrance compositions and other compositions which contain naturally occurring substances found in corals |
| 03/18/2009 | CN100469764C Vitamin D derivatives |
| 03/11/2009 | EP1212618B1 Effect of steroids on nmda receptors depends on subunit composition |
| 03/05/2009 | WO2009007454A3 8-beta-substituted estratrienes as selectively active estrogens |
| 03/05/2009 | US20090062558 Process for preparing Estrogen-antagonistic 11 beta-Fluoro-17alpha-alkylestra-1,3,5(10)-triene-3,17-diols having a 7alpha-(xi-Alkylamino-omega-perfluoroalkyl)alkyl side chain and alpha-Alkyl(amino)-omega-perfluoro(alkyl)alkanes and Processes for their Preparation |
| 03/03/2009 | US7498322 Antiangiogenic agents |
| 02/26/2009 | US20090054385 Solid inhalation formulations of dehydroepiandrosterone derivatives |
| 02/26/2009 | US20090053143 Liquid inhalation formulations of dehydroepiandrosterone derivatives |
| 02/25/2009 | CN101374854A Process for production of steroids |
| 02/24/2009 | US7495115 Androgens conjugated with mammalian proteins; diagnosis or treatment of solid cancer and hematological malignancies; exhibit synergistic action together with a cytoskeleton-acting drug; prostate cancer |
| 02/24/2009 | US7495026 Neo-tanshinlactone and analogs as potent and selective anti-breast cancer agents |
| 02/19/2009 | WO2009022477A1 Norbornene polymers bearing biologically active substances bonded thereto, proces for production of the same and use thereof |
| 02/18/2009 | EP2024383A2 Crystalline forms of 11 beta-(4-acetylphenyl)-20,20,21,21,21-pentafluor-17alpha- hydroxy-19-nor-17 -pregna-4,9-dien-3-one |
| 02/18/2009 | CN100462364C 6 alpha-bromo- androstane-4-ene-3,17-dione high efficient synthesis method |
| 02/12/2009 | DE102007025454B4 Verwendung von a,ß-ungesättigten Carbonylverbindungen als Quenchreagenzien für die Birch-Reduktion Use of alpha, beta-unsaturated carbonyl compounds as quench reagents for the Birch reduction |
| 02/11/2009 | CN101362789A Method for producing dehydroepiandrosterone |
| 02/11/2009 | CN101362788A High-efficiency synthesis method of 6 alpha-bromo-carboxyandrost-4-ene-3,17-dione |
| 02/11/2009 | CN100459980C 7-Hydroxyepiandrosterone having neuroprotective activity |
| 02/04/2009 | CN101358965A Method for detecting norethindrone and special ELISA kit thereof |
| 02/04/2009 | CN100457771C Extraction of 4-androstenedione from oil phase of fermenting liquid |
| 01/29/2009 | US20090029957 8-beta-substituted estratrienes as selectively active estrogens |
| 01/29/2009 | US20090028904 Novel cochleate formulations |
| 01/28/2009 | CN101353366A Steroidal estrogen medicament for treating tumor |
| 01/28/2009 | CN101353365A Preparation of progestational hormone |
| 01/22/2009 | US20090023896 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds |
| 01/22/2009 | US20090023695 METHOD OF MAKING AND USING 7alpha,11beta-DIMETHYL-17beta-HYDROXYESTR-4-EN-3-ONE 17-UNDECANOATE |
| 01/21/2009 | CN100453549C 8 Beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 01/20/2009 | US7479290 for preparing Solanum alkaloid glycosides; Solanum is subjected to methanol extraction, drying the extract and dissolving in a weak volatile acid and centrifuged, the supernatant is precipitated using a volatile base; high purity |
| 01/15/2009 | WO2009007454A2 8-beta-substituted estratrienes as selectively active estrogens |
| 01/15/2009 | US20090018356 Crystalline polymorph of exemestane |
| 01/15/2009 | US20090017003 Thiosulfonate anti-inflammatory agents |
| 01/15/2009 | CA2692727A1 8-beta-substituted estratrienes as selectively active estrogens |
| 01/14/2009 | EP2014672A1 8-beta-substituted estratrienes as selectively active estrogens |
| 01/14/2009 | EP2012773A2 Drugs and uses |
| 01/08/2009 | US20090012319 Process for the preparation 2-substituted-derivatives of estrone and estradiol |
| 01/08/2009 | US20090012013 Steroid modified solatrioses |
| 01/07/2009 | EP2010555A2 Method for preparing 4-[17beta -methoxy-17 -alpha methoxymethyl-3-oxoestra-4,9-dien-11beta -yl]benzaldehyde (e)-oxime (asoprisnil) |
| 01/07/2009 | EP1246835B1 Substituted sapogenins and their use |
| 12/25/2008 | US20080318875 Core 2 Glcnac-T Inhibitors |
| 12/24/2008 | WO2008157635A2 Synthetic bile acid composition, method, and preparation |
| 12/24/2008 | CA2789109A1 Synthetic bile acid composition, method, and preparation |
| 12/18/2008 | US20080312266 Steroidal Compounds For Inhibiting Steroid Sulphatase |
| 12/18/2008 | US20080312202 6-substituted estradiol derivatives and methods of use |
| 12/18/2008 | US20080311667 Exogenous Markers for Oxidative Stress |
| 12/16/2008 | CA2339835C Use of estrogenic compounds as anti-fungal agents |
| 12/11/2008 | US20080306285 Heat-Labile Prodrugs |
| 12/11/2008 | DE102007026877A1 Verwendung des Fibroblastenwachstumsfaktors 7 (Fgf7) und des Rezeptors Fgfr2b als Biomarker Use of the fibroblast growth factor 7 (FGF7) and the receptor FGFR2b as biomarkers |
| 12/09/2008 | US7462721 Aza-quinolinol phosphonate integrase inhibitor compounds |
| 12/09/2008 | US7462610 Prostate cancer treatment |